Health Information Center

Axcan Pharma Inc.-Company Report provides up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies.

Scope of the reports

Accessing accurate, current and comprehensive content on private companies can be challenging and Life Science Analytics has created a suite of reports that deliver the latest information on over 1,000 private firms. Each report provides a corporate overview and business description along with detail on the company’s management team and its products. . Continue reading ‘Axcan Pharma Inc.-Company Report’ »

Alliance Pharma plc-Company Report

Bharatbook.com added a new report on “Alliance Pharma plc-Company Report” into its market report catalogue for reselling.

Alliance Pharma plc-Company Report provides up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies.

Scope of the reports

Accessing accurate, current and comprehensive content on private companies can be challenging and Life Science Analytics has created a suite of reports that deliver the latest information on over 1,000 private firms. Each report provides a corporate overview and business description along with detail on the company’s management team and its products. . Continue reading ‘Alliance Pharma plc-Company Report’ »

Oncothyreon, Inc.-Therapeutic Competitors includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication and stage of development, and competitors by therapeutic indication. The report also includes recent company news updates.

Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the predicted likelihood of clinical success for each pipeline product. Every Competitor Report compares the company against its primary competitors by individual therapeutic indication. Continue reading ‘Oncothyreon, Inc.-Therapeutic Competitors’ »

GlobalData’s medical device report offering, “Argentina Diabetes Care Devices Market Outlook to 2016″ provides key market data on the Argentina diabetes care devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories – Glucose Monitoring and Insulin Delivery. This medical equipment report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

•Market size and company share data for two diabetes care devices market categories – Glucose Monitoring and Insulin Delivery. Continue reading ‘Argentina Diabetes Care Devices Market Outlook to 2016’ »

Cancer is recognized as a major cause of mortality world over; accounting for 7.4 million (or 13%) of all deaths in 2004. The WHO estimates the incidence of cancer to continue rising to reach an estimated 9.2 million deaths in 2015. The rising prevalence of the disease forms one of the major factors driving the growth of the oncology biomarkers market.

Biomarker are chemical, physical, or biological parameters that can be used to indicate disease states. Oncology biomarkers facilitate high-speed, non-invasive cancer diagnosis; and are believed to enhance early cancer detection and screening. The demand for oncology biomarkers is also increasing because of their ability to trace the exact type of cancer and to target patient-specific molecular structure.

The oncology biomarkers market offers high-growth opportunities with the numerous initiatives to encourage biomarker-based cancer treatment. Government agencies such as Food and Drug Administration (FDA) and the National Cancer Institute (NCI) ) are have taken an active interest in the field, especially with the declining success to failure rate of oncology drugs Continue reading ‘Global Oncology Biomarkers Market’ »

Argenta-Company Report provides up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies.

Scope of the reports

Accessing accurate, current and comprehensive content on private companies can be challenging and Life Science Analytics has created a suite of reports that deliver the latest information on over 1,000 private firms. Each report provides a corporate overview and business description along with detail on the company’s management team and its products. . Continue reading ‘Argenta-Company Report’ »

Avexa Limited-Company Report provides up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies.

Scope of the reports

Accessing accurate, current and comprehensive content on private companies can be challenging and Life Science Analytics has created a suite of reports that deliver the latest information on over 1,000 private firms. Each report provides a corporate overview and business description along with detail on the company’s management team and its products. . Continue reading ‘Avexa Limited-Company Report’ »

Astellas Pharma Canada, Inc.-Company Report provides up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies.

Scope of the reports

Accessing accurate, current and comprehensive content on private companies can be challenging and Life Science Analytics has created a suite of reports that deliver the latest information on over 1,000 private firms. Each report provides a corporate overview and business description along with detail on the company’s management team and its products. . Continue reading ‘Astellas Pharma Canada, Inc.-Company Report’ »

Eye care value sales increased by 8% to reach EUR4 million in 2009. In eye care, standard eye care was the fastest-growing category, up by 9% to reach over EUR3 million. Consumers became increasingly savvy about the appropriate use of eye care, while the main target group for eye care still remained contact lens users.

Eye Care Products in Austria report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2005-2009, allowing you to identify the sectors driving growth. Forecasts to 2014 illustrate how the market is set to change. Continue reading ‘Eye Care – Austria’ »

Hikma Pharmaceuticals PLC-Company Report provides up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies.

Scope of the reports

Accessing accurate, current and comprehensive content on private companies can be challenging and Life Science Analytics has created a suite of reports that deliver the latest information on over 1,000 private firms. Each report provides a corporate overview and business description along with detail on the company’s management team and its products. . Continue reading ‘Hikma Pharmaceuticals PLC-Company Report’ »